BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31176034)

  • 1. Should fast breathing pneumonia cases be treated with antibiotics? The scientific rationale for revisiting management in Low and Middle income countries.
    Jehan F; Nisar I; Kerai S; Brown N; Ambler G; Zaidi AKM
    Int J Infect Dis; 2019 Aug; 85():64-66. PubMed ID: 31176034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double blind community-based randomized trial of amoxicillin versus placebo for fast breathing pneumonia in children aged 2-59 months in Karachi, Pakistan (RETAPP).
    Jehan F; Nisar MI; Kerai S; Brown N; Balouch B; Hyder Z; Ambler G; Ginsburg AS; Zaidi AK
    BMC Infect Dis; 2016 Jan; 16():13. PubMed ID: 26758747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-inferiority designs comparing placebo to a proven therapy for childhood pneumonia in low-resource settings.
    May S; Brown SP; Schmicker RH; Emerson SS; Nkwopara E; Ginsburg AS
    Clin Trials; 2020 Apr; 17(2):129-137. PubMed ID: 31814441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a prognostic risk score to aid antibiotic decision-making for children aged 2-59 months with World Health Organization fast breathing pneumonia in Malawi: An Innovative Treatments in Pneumonia (ITIP) secondary analysis.
    McCollum ED; Brown SP; Nkwopara E; Mvalo T; May S; Ginsburg AS
    PLoS One; 2019; 14(6):e0214583. PubMed ID: 31220085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placebo vs Amoxicillin for Nonsevere Fast-Breathing Pneumonia in Malawian Children Aged 2 to 59 Months: A Double-blind, Randomized Clinical Noninferiority Trial.
    Ginsburg AS; Mvalo T; Nkwopara E; McCollum ED; Ndamala CB; Schmicker R; Phiri A; Lufesi N; Izadnegahdar R; May S
    JAMA Pediatr; 2019 Jan; 173(1):21-28. PubMed ID: 30419120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of treatment failure for non-severe childhood pneumonia in developing countries--systematic literature review and expert survey--the first step towards a community focused mHealth risk-assessment tool?
    McCollum ED; King C; Hollowell R; Zhou J; Colbourn T; Nambiar B; Mukanga D; Burgess DC
    BMC Pediatr; 2015 Jul; 15():74. PubMed ID: 26156710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic use in children hospitalised with pneumonia in Central Vietnam.
    Nguyen PT; Tran HT; Fitzgerald DA; Graham SM; Marais BJ
    Arch Dis Child; 2020 Aug; 105(8):713-719. PubMed ID: 32079569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute respiratory infections: the forgotten pandemic. Communiqué from the International Conference on Acute Respiratory Infections, held in Canberra, Australia, 7-10 July 1997.
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):2-4. PubMed ID: 9562104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can child pneumonia in low-resource settings be treated without antibiotics? A systematic review & meta-analysis.
    Walker PJ; Wilkes C; Duke T; Graham HR;
    J Glob Health; 2022 Nov; 12():10007. PubMed ID: 36370376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-treatment of children with community health worker-diagnosed fast-breathing pneumonia in rural Malawi: exploratory subanalysis of a prospective cohort study.
    King C; Colbourn T; Mankhambo L; Beard J; Hay Burgess DC; Costello A; Izadnegahdar R; Lufesi N; Mwansambo C; Nambiar B; Johnson ES; Platt RW; Mukanga D; McCollum ED
    BMJ Open; 2016 Nov; 6(11):e011636. PubMed ID: 27852705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of oral amoxicillin with placebo for the treatment of world health organization-defined nonsevere pneumonia in children aged 2-59 months: a multicenter, double-blind, randomized, placebo-controlled trial in pakistan.
    Hazir T; Nisar YB; Abbasi S; Ashraf YP; Khurshid J; Tariq P; Asghar R; Murtaza A; Masood T; Maqbool S
    Clin Infect Dis; 2011 Feb; 52(3):293-300. PubMed ID: 21189270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-based antibiotic delivery for possible serious bacterial infections in neonates in low- and middle-income countries.
    Duby J; Lassi ZS; Bhutta ZA
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD007646. PubMed ID: 30970390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age specific fast breathing in under-five diarrheal children in an urban hospital: Acidosis or pneumonia?
    Nuzhat S; Ahmed T; Kawser CA; Khan AI; Islam SMR; Shahrin L; Shahunja KM; Shahid ASMSB; Al Imran A; Chisti MJ
    PLoS One; 2017; 12(9):e0185414. PubMed ID: 28953928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geographically linked risk factors for enrolment into a fast breathing child pneumonia trial in Lilongwe, Malawi: an Innovative Treatments in Pneumonia (ITIP) secondary analysis.
    Nkwopara E; Schmicker R; Mvalo T; May S; Ginsburg AS
    BMJ Open Respir Res; 2019; 6(1):e000414. PubMed ID: 31179007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review on antibiotic therapy for pneumonia in children between 2 and 59 months of age.
    Lassi ZS; Das JK; Haider SW; Salam RA; Qazi SA; Bhutta ZA
    Arch Dis Child; 2014 Jul; 99(7):687-93. PubMed ID: 24431417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of simple clinical signs to predict pneumonia in young Gambian children: the influence of malnutrition.
    Falade AG; Tschäppeler H; Greenwood BM; Mulholland EK
    Bull World Health Organ; 1995; 73(3):299-304. PubMed ID: 7614661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel electronic algorithm using host biomarker point-of-care tests for the management of febrile illnesses in Tanzanian children (e-POCT): A randomized, controlled non-inferiority trial.
    Keitel K; Kagoro F; Samaka J; Masimba J; Said Z; Temba H; Mlaganile T; Sangu W; Rambaud-Althaus C; Gervaix A; Genton B; D'Acremont V
    PLoS Med; 2017 Oct; 14(10):e1002411. PubMed ID: 29059253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of serious adverse events in a paediatric fast breathing pneumonia clinical trial in Malawi.
    Nkwopara E; Schmicker R; Mvalo T; Phiri M; Phiri A; Couasnon M; McCollum ED; Ginsburg AS
    BMJ Open Respir Res; 2019; 6(1):e000415. PubMed ID: 31548894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low rates of treatment failure in children aged 2-59 months treated for severe pneumonia: a multisite pooled analysis.
    Fox MP; Thea DM; Sadruddin S; Bari A; Bonawitz R; Hazir T; Bin Nisar Y; Qazi SA;
    Clin Infect Dis; 2013 Apr; 56(7):978-87. PubMed ID: 23264361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods for conducting a double-blind randomized controlled clinical trial of three days versus five days of amoxicillin dispersible tablets for chest indrawing childhood pneumonia among children two to 59 months of age in Lilongwe, Malawi: a study protocol.
    Ginsburg AS; May SJ; Nkwopara E; Ambler G; McCollum ED; Mvalo T; Phiri A; Lufesi N; Sadruddin S
    BMC Infect Dis; 2018 Sep; 18(1):476. PubMed ID: 30241517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.